SentoClone® Compared to Reference Treatment in Advanced Malignant Melanoma

Update Il y a 4 ans
Reference: NCT00991250

Woman and Man

  • | Country :
  • Sweden
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to elucidate whether SentoClone® gives improved treatment responses in patients with advanced malignant melanoma in comparison to established reference treatment(s).


Inclusion criteria

  • Malignant Melanoma

Links